美国食品药品监督管理局通知。瑞达唑已获批用于治疗艾滋病病毒。
FDA notifications. Reyataz is approved for HIV treatment.
出版信息
AIDS Alert. 2003 Sep;18(9):119-20.
PMID:14686309
Abstract
Reyataz, protease inhibitor, is to be used in combination with other antiretroviral agents for the treatment of patients with HIV infection. The most common laboratory abnormality observed is hyperbilirubinemia.
摘要
抗蛋白酶药物 Reyataz 需与其他抗逆转录病毒药物联合使用，用于治疗 HIV 感染患者。观察到的最常见实验室异常是高胆红素血症。
Zotero 插件